"Workplace Substance Use: New Interventions with Relapse Prevention"

February 23, 2018

Please Join SFV EAPA for Breakfast, Networking and Continuing Education Earn two CE credits at February's San Fernando Valley Employee Assistance Providers Association meeting:

“Workplace Substance Use: New Interventions with Relapse Prevention"

Presented by David Lisonbee, CEO, Twin Town Treatment Centers


  • To further understand medical and psychosocial interventions and relapse prevention techniques leading toward a more safe and secure workplace;
  • Understand provider services and assets needed for making wise medical and treatment referrals;
  • Become aware and able to implement improved workplace recovery supports.

David LisonbeeDavid Lisonbee is President and Chief Executive Officer of Twin Town Treatment Centers, which operates a network of six Los Angeles and Orange County outpatient addiction treatment programs. Possessing over thirty years of behavioral health management and executive experience, Mr. Lisonbee oversees corporate governance, development, human resources, finance, compliance, quality management and clinical service. Prior to operating Twin Town Treatment Centers, Mr. Lisonbee developed and operated psychiatric hospitals and outpatient psychiatric programs.

Mr. Lisonbee has lectured on relapse prevention, engagement and retention in recovery, trends in evidence based treatment, and ethics in substance use disorder treatment. He has presented to numerous provider association conferences, provider and EAP organizations, hospitals, and managed care organizations.

David Lisonbee:
Gary Enos, Behavioral Healthcare Magazine, (954) 960-5527
Dee McGraw, C4 Recovery, West Coast Symposium on Addictive Disorders (616) 581-4855
Allen Berger, PhD, The Evolution of Addiction Treatment Conference (818) 584-4795

Presenter Conflict of Interest:
David Lisonbee is owner and operater of Twin Town Treatment Centers, a network of six intensive outpatient treatment programs in Southern California.

Session Description:
Employee assistance programs and counselors need to understand the clinical basis of and effective interventions for the treatment substance use disorders. Relapse remains a great concern, especially when it poses dangers in the workplace.

Medical research has revolutionized our currently understanding of the disease of addiction. The goal of this presentation is to expose the EAP to the biological underpinnings of the disease and what medical and psychosocial interventions are available to move substance use disorders to remission and prevent their relapse.

Detecting and intervening with drug and alcohol use disorders and predicting their relapse through observation and assessment is a primary theme of this presentation.

This presentation will also outline the current research and developments in understanding substance use disorders and their relapse. Various forms of evidence based treatment will described so that the EAP has an opportunity to provide more effective assessment tools and referrals. Finally, preventing relapse will be recommended to attendees through the development of workplace supports for the recovering employee.

Though this presentation will not cover state-by-state legal recommendations for preventing substance use in the workplace, the facts about detecting the disease, its relapse, and the evidence for specific treatment interventions will assist the EAP and management team to make more informed and productive decisions.

Citations (source materials):
Drugs, Brains, and Behavior: The Science of Addiction. National Institute on
Drug Abuse Web site. http://www.drugabuse.gov/publications/drugs-brains-behavior-science-addiction/drug-abuse-addiction.

Tetrault JM, Fiellin DA. Drugs. 2012;72:217-228.

Substance Abuse and Mental Health Services Administration, Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings, NSDUH Series H-46, HHS Publication No. (SMA) 13-4795. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2013.

Baldini A et al. Prim Care Companion CNS Disord. 2012;14(3).

Crews FT et al. Brain Behav Immun. 2011;25(suppl 1):S4-S12. Kosten TR, George TP. Sci Pract Perspect. 2002;1(1):13-20.

JAMA. 2013; 309(17): 1821 – 1827. doi:101011/jama.2013.3411

Messing RO. In: Harrison’s Principles of Internal Medicine. 2001:2557-2561.
Prolonged drug use changes the brain in fundamental and long-lasting ways - both structural and functional changes occur (Ernst T. Neurology. 2000;54.)

Drugs change brain circuits and motivational priorities  (J Acquir Immune Defic Syndr 34(5):467-474, 2003.)

Lee, M., Silverman, S., Hans Hansen, Patel, V. & Manchikanti, Comprehensive Review of Opioid-Induced Hyperalgesia , Pain Physician 2011; 14:145-161 • ISSN 1533-3159

Fiellin DA. Am Fam Physician. 2006;73:1513-1514.

Soyka M et al. Int J Neuropsychopharmacol. 2008;11:641-653.

Kakko J et al. Lancet. 2003;361:662-668

The impact of residential and nonresidential drug treatment on recidivism among drug-involved probationers: A survival analysis. Krebs, C. P., Strom, K. J., Koetse, W. H., & Lattimore, P. K. (2009). Crime & Delinquency, 55, 442-471

The effectiveness of inpatient and outpatient treatment for alcohol abuse: the need to focus on mediators and moderators of setting effects, JOHN W. FINNEY, ANNETTE C. HAHN, RUDOLF H. MOOS Article first published online: 24 JAN 2006 DOI: 10.1046/j.1360-0443.1996.911217733.x Addiction Volume 91, Issue 12, pages 1773–1796, December 1996

Day Hospital and Residential Addiction Treatment: Randomized and Nonrandomized Managed Care Clients; Jane Witbrodt, Jason Bond, and Lee Ann Kaskutas Alcohol Research Group, Constance Weisner, University of California, San Francisco, Gary Jaeger; Kaiser Foundation Hospital, David Pating, Kaiser San Francisco Medical Center, Charles Moore Sacramento Kaiser Permanente, Journal of Consulting and Clinical Psychology Copyright 2007 by the American Psychological Association, 2007, Vol. 75, No. 6, 947–95

Relapse Prevention Therapy: A Cognitive-Behavioral Approach,  George A. Parks, Ph.D. and G. Alan Marlatt, Ph.D., September 1, 2000  

Irvin, J. E., Bowers, C.A., Dunn, M.E., and Wang, M.C. (1999). Efficacy of relapse prevention: A meta-analytic review. Journal of Consulting and Clinical Psychology.

Marlatt, G. A. & Gordon, J.R. (Ed.). (1985). Relapse Prevention: Maintenance strategies in the treatment of addictive behaviors. New York: Guilford Press.

Parks, G. A. and Marlatt, G. A. (1999) Relapse Prevention Therapy for Substance-Abusing Offenders: A Cognitive-Behavioral Approach in What Works: Strategic Solutions: The International Community Corrections Association Examines Substance Abuse edited by E. Latessa. Lanham, MD: American Correctional Association, p. 161- 233.

Program Costs:
Members: $15
Non-Members: $20
Students with I.D: $10

2 PDH / CEU Credits for CEAP,  LCSW, MFT

RSVP: For details, special accommodations or to RSVP, please contact Naheed Carter at Naheed.awan@gmail.com
or (240) 381-8154. Space is limited.

Friday, February 23, 2018
8:30 am Networking
9-11 am Program

Foundations Recovery Network
17167 Ventura Blvd, Encino, CA 91316

The February 2018 meeting is sponsored by:
Center for Discovery

Meeting host:
Foundations Recovery Network


Return to home page Return to home page View the annual calendar of events View our member resources page Learn more about our Board of Directors View our contact list Return to home page About SFV EAPA Map + Directions to our meeting place Frequently Asked Questions Links to external resources Site Map Contact Us